Interview with Sheila Kelly, Chief Executive, Proprietary Association of Great…
Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed…
Address: PAGB, Vernon House, Sicilian Avenue, London , WC1A 2QS, United Kingdom
Tel: +44 (0)20 7242 8331
PAGB is the UK trade association for manufacturers of branded over-the-counter medicines and food supplements.
Over-the-counter is the term used for medicines that can be bought in pharmacies and in other retail outlets without a prescription. Some of the medicines can only be sold in pharmacies and pharmacists are required to supervise their sales and ask questions before supplying them to customers.
Established in 1919, the association was founded to promote responsible consumer healthcare by controlling the advertising of all the medicines of the companies in membership through a code of advertising practice. This remains a core activity for the association although the PAGB Medicines Advertising Code now sits within a legal framework.
For more than 20 years, PAGB’s research and policy development has focused on framing self care as a level of care in the NHS and its policies.
The Department of Health publication ‘Self care – A real choice, Self care support – a practical option’ (2005) defines self care as:
‘…the actions people take for themselves, their children and their families to stay fit and maintain good physical and mental health; meet social and psychological needs; prevent illness or accidents; care for minor ailments and long-term conditions; and maintain health and wellbeing after an acute illness or discharge from hospital.’
Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed…
US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central…
Jameel Zayed of Leyton, the UK’s leading innovation funding consultancy, highlights the British pharmaceutical…
Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British…
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…
With Brexit now confirmed, the UK government has been playing up the country’s scientific credentials. The aim is…
Friday January 31 2020 was officially dubbed “Brexit Day” as the UK finally left the EU, following British…
Although biotech financing in the UK took a hit last year in large part thanks to uncertainty around Brexit, 2019…
GW Pharmaceuticals reports that sales of its CBD drug Epidiolex more than doubled in the second quarter of 2019,…
Formed in 2015, listed UK start-up Amryt targets rare diseases with high unmet medical need. With one commercial…